Authors: POOL JL GUTHRIE RM LITTLEJOHN TW RASKIN P SHEPHARD AMM WEBER MA WEIR MR WILSON TW WRIGHT J KASSLERTAUB KB REEVES RA

Citation: Jl. Pool et al., DOSE-RELATED ANTIHYPERTENSIVE EFFECTS OF IRBESARTAN IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, American journal of hypertension, 11(4), 1998, pp. 462-470

Authors: SIMON TA GELARDEN T FREITAG SA KASSLERTAUB KB DAVIES R

Citation: Ta. Simon et al., SAFETY OF IRBESARTAN IN THE TREATMENT OF MILD-TO-MODERATE SYSTEMIC HYPERTENSION, The American journal of cardiology, 82(2), 1998, pp. 179-182

Authors: BEHOUNEK BD MCGOVERN ME KASSLERTAUB KB MARKOWITZ JS BERGMAN M BEDARD J LEITER L OLEARY TJ TAN MH TILDESLEY HD",BERTHEZENE,KREMPF,MOINADE,PASSA,WEMEAU,BIESENBACH,DAMMANN,ERHARD,HEBBELN,HUTH,MAHLA,MARTENS,PATSCH,SCHNEIDER,SCHOLTEN,TEUBER,WEISWEILER,"BARON H",KLEINMAN,"SEGAL P YESHURON D AWUNORRENNER C CONALGEN JC FEEK CM

Citation: Bd. Behounek et al., A MULTINATIONAL STUDY OF THE EFFECTS OF LOW-DOSE PRAVASTATIN IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND HYPERCHOLESTEROLEMIA, Clinical cardiology, 17(10), 1994, pp. 558-562

Authors: BEHOUNEK BD MARKOWITZ JS BERGMAN M MCGOVERN ME KASSLERTAUB KB VANHANEN H ELORANTA M JUVONEN J KANTOLA I KEKKI S KIVELA H KNUTAR F NISSEN M SALMI J SALONEN R TARPILA S TUNTURIHIHNALA H AMANN FW BERENDES G BONNER G DUBACH UC EGGSTEIN M FRANKENBERG HV FROER KL HOHL H HOPPE F KUMMER H MARZ W MOCCETTI T NOSEDA G REUTTER FW SCHWENKE R VOSSCHULTE G WAMBACH G WEIDMANN P BONNIER JJRM DEWEERD P HUIGE MC JANSEN LJ TERIJDT AJ TEVELDE K OLSSON AG LARSSON H ASPLUND J DAHLQVIST A LONNQVIST F FRITHZ G HOGLUND C KJELLSTROM T KUYLENSTIERNA J MOLLER B OSTERGREN J CRAMB R DAVIES J",IVERSON,"JOHNSTON GD MUNRO A PEACOCK I RITCHIE LD RITTER J RYLANCE PB SEVER PS SIMMONS RL

Citation: Bd. Behounek et al., EFFECTS OF PRAVASTATIN IN PATIENTS WITH SERUM TOTAL CHOLESTEROL LEVELS FROM 5.2 TO 7.8 MMOL LITER (200 TO 300 MG DL) PLUS 2 ADDITIONAL ATHEROSCLEROTIC RISK-FACTORS, The American journal of cardiology, 72(14), 1993, pp. 1031-1037